HCA Health Inc vs Modine Manufacturing Company — how do they compare? HCA Health Inc trades at $450.18 (market cap $96.35B), while Modine Manufacturing Company trades at $182 (market cap $9.66B). The key difference: HCA Health Inc is far larger — about 10× Modine Manufacturing Company's market cap, and HCA Health Inc pays a 0.7% dividend while Modine Manufacturing Company pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Modine Manufacturing Company for 33 Days on average.
| HCA | MOD | |
|---|---|---|
Market Cap | $96.35B | $9.66B |
Volume | 1,079,453 | 1,331,946 |
Sector | Health | Industrials |
52-Week High | $545.13 | $283.95 |
52-Week Low | $361.32 | $110.73 |
Typical Hold Time | 76 Days | 33 Days |
Enterprise Value | $146.88B | $10.09B |
Dividend Yield | 0.7% | — |
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $451.09, up 2.71% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q4 2025 and Q1-Q2 2026 exceeding expectations, supported by robust revenue growth from $70.6B in 2024 to $75.6B in 2025. Valuation metrics remain attractive with P/E of 14.92 and P/S of 1.31, while technical indicators signal bullish momentum above key support levels.
The outlook remains positive with 63% analyst buy ratings and $461.12 consensus target, though legal investigations and high debt levels pose risks. Revenue growth and operational efficiency provide upside potential, but investors should monitor regulatory developments and debt management closely given the 80.9% debt-to-asset ratio in 2025.
Modine Manufacturing (MOD) trades at $184.32, down 2.7% on the day, amid a recent spin-off of its Performance Technologies unit. The stock exhibits bearish technical signals with support at $177 and resistance at $187. Fundamentally, the company reported strong Q2 2026 earnings of $1.53 per share, beating estimates, but faces margin compression with net income margin declining from 7.12% in 2025 to 4.27% in 2026. Analyst sentiment remains positive with a consensus price target of $331.25 and 10 buy ratings.
The outlook for MOD is mixed; the spin-off could streamline operations and focus on thermal management growth, but integration risks and margin pressures pose challenges. The stock trades at a high P/E of 67.87, suggesting premium valuation. Upside depends on execution of the new corporate strategy and data center cooling expansion, while downside risks include competitive pressures and macroeconomic headwinds affecting industrial demand.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →